Metraipolis › archive › dc_26a9099cbdbf

Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation — Europe PMC PMID:42694733

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42694733
DOI
10.3389/fimmu.2026.1896755
License (as archived)
solo-consultazione
Archived
2026-10-07T17:19:19.606Z
SHA-256 of the archived text
dab8a2a7edc322bc30fbbc04c4a5f418b49b4c2c6a179dec1226ef113e6e443a
Stable URL of this page
https://metraipolis.com/documento/dc_26a9099cbdbf

How to cite

Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation — Europe PMC PMID:42694733 — Europe PMC (en), https://europepmc.org/article/MED/42694733 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26a9099cbdbf (Metraipolis archive dc_26a9099cbdbf, sha256 dab8a2a7edc322bc30fbbc04c4a5f418b49b4c2c6a179dec1226ef113e6e443a)
BibTeX
@misc{dc26a9099cbdbf,
  title = {Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation — Europe PMC PMID:42694733},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42694733},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26a9099cbdbf; sha256 dab8a2a7edc322bc30fbbc04c4a5f418b49b4c2c6a179dec1226ef113e6e443a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42694733. Agents can read the archived copy with the MCP tool read_document.